Characteristics | Â | ST131 subclones, number of isolates (%) | P a | ||||
---|---|---|---|---|---|---|---|
Total | H30Rx | H30 non-Rx | H41 | H41 vs H30 non -Rx | H41 vs H30-Rx | H30 Rx vs H30 non-Rx | |
N = 83 (%) | n = 13 | n = 40 | n = 30 |  |  |  | |
PCR O type | |||||||
 O25b | 55(66.3%) | 12(92.3%) | 40(100%) | 3(10.0%) | < 0.001 | < 0.001 |  |
 O16 | 28(33.7%) | 1(7.7%) | 0 | 27(90.0%) |  |  |  |
Antimicrobial resistance | |||||||
 ATM | 30(36.1%) | 12(92.3%) | 11(27.5%) | 7(23.3%) |  | < 0.001 | < 0.001 |
 CAZ | 22(26.5%) | 10(76.9%) | 5(12.5%) | 7(23.3%) |  | 0.002 | < 0.001 |
 CTX | 59(71.1%) | 12(92.3%) | 28(70%) | 19(63.3%) |  |  |  |
 FEP | 26(31.3%) | 11(84.6%) | 10(25.0%) | 5(16.7%) |  | < 0.001 | < 0.001 |
 TZP | 1(1.2%) | 0 | 0 | 1(3.3%) |  |  |  |
 CIP | 58(69.9%) | 13(100%) | 40(100%) | 5(16.7%) | < 0.001 | < 0.001 |  |
 LEV | 58(69.9%) | 13(100%) | 40(100%) | 5(16.7%) | < 0.001 | < 0.001 |  |
 AMK | 7(8.4%) | 3(23.1%) | 1(2.50%) | 3(10.0%) |  |  | 0.042 |
 SXT | 56(67.5%) | 10(76.9%) | 24(60.0%) | 22(73.3%) |  |  |  |
bla CTX-M type | |||||||
 CTX-M-14 | 37(44.6%) | 0 | 22(55.0%) | 15(50.0%) |  | 0.001 | < 0.001 |
 CTX-M-15 | 22(26.5%) | 12(92.3%) | 7(17.5%) | 3(10.0%) |  | < 0.001 | < 0.001 |
 CTX-M-14,15 | 2(2.40%) | 0 | 2(5.0%) | 0 |  |  |  |
 CTX-M-123 | 1(1.2%) | 0 | 0 | 1(3.3%) |  |  |  |
 No ESBLb | 21(25.3%) | 1(7.7%) | 11(27.5%) | 9(30.0%) |  |  |  |
FQR genesc | |||||||
 5 gyrA, parC and parE mutationsd | 51(61.4%) | 13(100%) | 35(87.5%) | 3(10.0%) | < 0.001 | < 0.001 |  |
  aac(6′)-Ib-cr | 14(16.9%) | 10(76.9%) | 0 | 4(13.3%) | 0.012 | < 0.001 | < 0.001 |
  qnr | 4(4.8%) | 0 | 2(5.0%) | 2(6.70%) |  |  |  |
Adhesins | |||||||
  papAH | 22 (26.5%) | 12(92.3%) | 6 (15.0%) | 4(13.3%) |  | < 0.001 | < 0.001 |
  papC | 23 (27.7%) | 13(100%) | 6 (15.0%) | 4(13.3%) |  | < 0.001 | < 0.001 |
  papEF | 22 (26.5%) | 12(92.3%) | 7(17.5%) | 3(10.0%) |  | < 0.001 | < 0.001 |
  papG allele I | 0 | 0 | 0 | 0 |  |  |  |
  papG allele II | 21 (25.3%) | 12(92.3%) | 6 (15.0%) | 3(10.0%) |  | < 0.001 | < 0.001 |
  sfa/focDE | 1 (1.2%) | 0 | 1(2.50%) | 0 |  |  |  |
  focG | 0 | 0 | 0 | 0 |  |  |  |
  afa/draBC | 7 (8.4%) | 0 | 2(5.0%) | 5(16.7%) |  |  |  |
  fimH | 82 (98.8%) | 13(100%) | 39(97.5%) | 30(100%) |  |  |  |
  gafD | 0 | 0 | 0 | 0 |  |  |  |
  sfaS | 7 (8.4%) | 3(23.1%) | 3(7.5%) | 1(3.3%) |  |  |  |
Toxins | |||||||
  hlyA | 14 (16.9%) | 11(84.6%) | 1(2.50%) | 2(6.70%) |  | < 0.001 | < 0.001 |
  cnf1 | 10 (12.0%) | 8(61.5%) | 1(2.50%) | 1(3.3%) |  | 0.002 | < 0.001 |
  cdtB | 0 | 0 | 0 | 0 |  |  |  |
  cvaC | 3 (3.6%) | 0 | 0 | 3(10.0%) | 0.042 |  |  |
Siderophores | |||||||
  fyuA | 81 (97.6%) | 13(100%) | 38(95.0%) | 30(100%) |  |  |  |
  iutA | 77 (92.8%) | 13(100%) | 38(95.0%) | 26(86.7%) |  |  |  |
Capsules | |||||||
  kpsMT II | 62 (74.7%) | 9(69.2%) | 33(82.5%) | 20(66.7%) |  |  |  |
  kpsMT III | 0 | 0 | 0 | 0 |  |  |  |
  kpsMT K1 | 10 (12.0%) | 2(15.4%) | 5(12.5%) | 3(10.0%) |  |  |  |
  kpsMT K5 | 47 (56.6%) | 11(84.6%) | 29(72.5%) | 7(23.3%) | < 0.001 | 0.001 |  |
Miscellaneous | |||||||
  nfaE | 0 | 0 | 0 | 0 |  |  |  |
  rfc | 0 | 0 | 0 | 0 |  |  |  |
  malX | 76 (91.6%) | 13(100%) | 37(92.5%) | 26(86.7%) |  |  |  |
  traT | 73 (88.0%) | 13(100%) | 32(80.0%.) | 28(93.3%) |  |  |  |
 Virulence scorese | 7 | 9 | 7 | 6 |  | 0.001 | 0.001 |